DD Q1 2026 Earnings Call Summary | Stock Taper
Logo
DD

DD — DuPont de Nemours, Inc.

NYSE


Q1 2026 Earnings Call Summary

May 5, 2026

DuPont Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics

  • Net Sales: $1.7 billion, up 4% year-over-year, driven by 2% organic growth and a 2% currency benefit.
  • Operating EBITDA: $414 million, a 15% increase year-over-year, with a margin of 24.6%, up 230 basis points.
  • Adjusted EPS: $0.55, a 53% increase year-over-year; on a pro forma basis, EPS was up 20%.
  • Free Cash Flow: Transaction-adjusted free cash flow of $147 million, with a conversion rate of 65%.
  • Segment Performance:
    • Healthcare & Water Technologies: Net sales of $806 million, up 6% (3% organic growth).
    • Diversified Industrials: Net sales of $875 million, up 3% (flat organic growth).

2. Strategic Updates and Business Highlights

  • DuPont completed the divestiture of its Aramids business on April 1, 2026, and plans to launch a $275 million accelerated share repurchase.
  • The company issued its 2026 sustainability report and set new 2035 sustainability goals focusing on sustainable innovation and operational resilience.
  • Continued investment in R&D and digital capabilities, including a collaboration with an AI-driven platform to enhance product development.
  • The company is implementing its 80/20 strategy in Diversified Industrials to enhance margins without significant top-line impact.

3. Forward Guidance and Outlook

  • Full-Year 2026 Guidance:
    • Net sales expected to be approximately $7.185 billion, reflecting a 4% organic growth.
    • Operating EBITDA projected at $1.745 billion.
    • Adjusted EPS guidance raised to $2.35 - $2.40 per share.
  • Q2 2026 Guidance:
    • Estimated net sales of about $1.8 billion and operating EBITDA of about $430 million.
    • Anticipated organic sales growth of 3% year-over-year.

4. Bad News, Challenges, or Points of Concern

  • Middle East Conflict: Logistics disruptions due to the ongoing conflict impacted sales, particularly in the water business, with $10 million in sales unable to ship in Q1. The company is cautious about potential macroeconomic headwinds.
  • Construction Market Weakness: Continued softness in construction markets is expected to result in flat growth for the year.
  • Stranded Costs: Approximately $30 million in stranded costs are being managed, with $10 million expected to be removed this year.
  • Pricing Pressures: Increased input costs are anticipated, with the company implementing price increases to offset these costs.

5. Notable Q&A Insights

  • 80/20 Strategy: The company is progressing well, with expectations for margin improvements but minimal top-line impact.
  • Water Business: Despite the challenges, the company expects to maintain mid-single-digit growth in the water segment for the year, with large projects anticipated in the second half.
  • Healthcare Growth: Strong demand driven by aging populations and healthcare access is expected to continue supporting growth in the healthcare segment.
  • Operational Improvements: Strong productivity gains contributed to margin expansion, with a mix of favorable product mix and operational efficiencies.
  • Future M&A: The company remains open to acquisitions to enhance its portfolio, particularly in healthcare, while maintaining a disciplined approach to capital allocation.

Overall, DuPont's Q1 2026 results reflect a strong operational start to the year, with solid financial performance and strategic initiatives aimed at long-term growth, despite facing challenges from geopolitical tensions and market softness in certain sectors.